Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Continuous, categorical and mixture models of DSM-IV alcohol and cannabis use disorders in the Australian community.

Baillie AJ, Teesson M.

Addiction. 2010 Jul;105(7):1246-53. doi: 10.1111/j.1360-0443.2010.02951.x. Epub 2010 May 14.

PMID:
20491729
2.

Sexual orientation and substance use trajectories in emerging adulthood.

Talley AE, Sher KJ, Littlefield AK.

Addiction. 2010 Jul;105(7):1235-45. doi: 10.1111/j.1360-0443.2010.02953.x. Epub 2010 May 14.

3.

Gender moderates the impact of stereotype threat on cognitive function in cannabis users.

Looby A, Earleywine M.

Addict Behav. 2010 Sep;35(9):834-9. doi: 10.1016/j.addbeh.2010.04.004. Epub 2010 May 7.

PMID:
20483199
4.

Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence.

Spiga S, Lintas A, Migliore M, Diana M.

Addict Biol. 2010 Jul;15(3):266-76. doi: 10.1111/j.1369-1600.2010.00218.x. Epub 2010 May 11.

PMID:
20477755
5.

Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.

Sevy S, Robinson DG, Napolitano B, Patel RC, Gunduz-Bruce H, Miller R, McCormack J, Lorell BS, Kane J.

Schizophr Res. 2010 Jul;120(1-3):101-7. doi: 10.1016/j.schres.2010.03.037. Epub 2010 May 14.

6.

The results of an experimental indoor hydroponic Cannabis growing study, using the 'Screen of Green' (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis.

Knight G, Hansen S, Connor M, Poulsen H, McGovern C, Stacey J.

Forensic Sci Int. 2010 Oct 10;202(1-3):36-44. doi: 10.1016/j.forsciint.2010.04.022. Epub 2010 May 13.

PMID:
20462712
7.

Endocannabinoids and their role in fatty liver disease.

Mallat A, Lotersztajn S.

Dig Dis. 2010;28(1):261-6. doi: 10.1159/000282100. Epub 2010 May 7. Review.

PMID:
20460921
8.

Psychiatric 'diseases' versus behavioral disorders and degree of genetic influence.

Bienvenu OJ, Davydow DS, Kendler KS.

Psychol Med. 2011 Jan;41(1):33-40. doi: 10.1017/S003329171000084X. Epub 2010 May 12. Review.

PMID:
20459884
9.

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors.

Soares Vde P, Campos AC, Bortoli VC, Zangrossi H Jr, GuimarĂ£es FS, Zuardi AW.

Behav Brain Res. 2010 Dec 1;213(2):225-9. doi: 10.1016/j.bbr.2010.05.004. Epub 2010 May 8.

PMID:
20457188
10.

Cannabinoid administration increases 5HT1A receptor binding and mRNA expression in the hippocampus of adult but not adolescent rats.

Zavitsanou K, Wang H, Dalton VS, Nguyen V.

Neuroscience. 2010 Aug 11;169(1):315-24. doi: 10.1016/j.neuroscience.2010.04.005. Epub 2010 May 8.

PMID:
20438810

Supplemental Content

Loading ...
Support Center